| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT05360238 | Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL | TERMINATED | PHASE1, PHASE2 | 2022-05-24 | 2024-04-12 | 2024-04-12 |
| NCT04109482 | Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN. | TERMINATED | PHASE1, PHASE2 | 2020-02-17 | 2023-05-17 | 2023-05-17 |